Use for diagnosis, prognosis, and monitoring of hematopoietic neoplasms. Microarray performed when karyotype results are reported as "normal" or "no growth."
Giemsa Band/Genomic Microarray (Oligo-SNP array)
If reflexed, add 7-12 days.
New York DOH Approval Status
Nondiluted bone marrow aspirate. Collect in a heparinized syringe
Do not freeze or expose to extreme temperatures. Transfer 3 mL bone marrow to a Green (Sodium Heparin). (Min: 0.5 mL)
Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
These studies involve culturing of living cells; therefore, turnaround times given represent average times, which are subject to multiple variables.
A processing fee will be charged if this procedure is canceled at the client's request after the test has been set up or if the specimen integrity is inadequate to allow culture growth.
If Chromosome Analysis is "normal" or "no growth," then Genomic Microarray testing will be added. Additional charges apply.
Specimens enrolled in external studies (e.g. COG studies) requireing additional work-up and/or supplementary data collection and submission will have the following charges added based on type and extent of work performed: Cytogenetics Study Submission - Basic (3006071) or Cytogenetics Study Submission - Extensive (3006072).
88237; 88264; if reflexed, add 81277; for COG studies, add 88299
|Component Test Code*||Component Chart Name||LOINC|
|0097605||Chromosome Analysis, Bone Marrow||50659-2|
|2009470||EER Chrom Analysis BM w/Rflx to Array|
- Bone marrow karyotype
- Cytogenomic SNP Microarray - Oncology
- genomic microarray